| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
39,597,000 |
| Market
Cap: |
5.21(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$56.73 - $176.11 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile TransMedics Group is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across various disease states. Co. has developed the Organ Care System (OCS), a portable organ perfusion and monitoring system that using Co.'s technology to replicate near-physiologic conditions for donor organs outside of the human body. The OCS was designed to perfuse donor organs with warm, oxygenated and nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile. Co.'s OCS products are one for each of lung, heart and liver transplantations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,500 |
| Total Buy Value |
$0 |
$0 |
$0 |
$155,000 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
12,418 |
15,908 |
158,656 |
741,324 |
| Total Sell Value |
$1,512,613 |
$1,783,274 |
$24,075,358 |
$84,408,150 |
| Total People Sold |
3 |
4 |
7 |
9 |
| Total Sell Transactions |
4 |
6 |
24 |
80 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ranganath Anil P. |
See remarks |
• – – |
2025-06-09 |
4 |
S |
$139.80 |
$95,903 |
D/D |
(686) |
13,955 |
|
6% |
|
| Basile Edward M |
|
– • – |
2025-05-27 |
4 |
S |
$126.45 |
$632,250 |
D/D |
(5,000) |
2,866 |
|
-2% |
|
| Basile Edward M |
|
– • – |
2025-05-27 |
4 |
OE |
$0.70 |
$3,500 |
D/D |
5,000 |
7,866 |
|
- |
|
| Weill David |
|
– • – |
2025-05-23 |
4 |
S |
$123.88 |
$90,680 |
D/D |
(732) |
12,134 |
|
-6% |
|
| Kania Edwin M Jr |
|
– • – |
2025-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,134 |
260,810 |
|
- |
|
| Basile Edward M |
|
– • – |
2025-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,134 |
2,866 |
|
- |
|
| Tobin James R |
|
– • – |
2025-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,134 |
4,059 |
|
- |
|
| Raines Merilee |
|
– • – |
2025-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,134 |
4,059 |
|
- |
|
| Weill David |
|
– • – |
2025-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,134 |
12,866 |
|
- |
|
| Gunderson Thomas James |
|
– • – |
2025-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,134 |
4,059 |
|
- |
|
| Lovell Stephanie |
|
– • – |
2025-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,134 |
4,059 |
|
- |
|
| Basile Edward M |
|
– • – |
2025-05-09 |
4 |
S |
$115.63 |
$693,780 |
D/D |
(6,000) |
732 |
|
-18% |
|
| Basile Edward M |
|
– • – |
2025-05-09 |
4 |
OE |
$0.70 |
$4,200 |
D/D |
6,000 |
6,732 |
|
- |
|
| Khayal Tamer I |
Chief Commercial Officer |
• – – |
2025-03-03 |
4 |
S |
$76.43 |
$183,967 |
D/D |
(2,407) |
36,042 |
|
-90% |
|
| Hassanein Waleed H |
President & CEO |
• • – |
2025-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
59,781 |
121,424 |
|
- |
|
| Hernandez Gerardo |
Chief Financial Officer |
• – – |
2025-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,521 |
15,984 |
|
- |
|
| Khayal Tamer I |
Chief Commercial Officer |
• – – |
2025-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
17,606 |
38,449 |
|
- |
|
| Ranganath Anil P. |
See remarks |
• – – |
2025-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
5,634 |
14,641 |
|
- |
|
| Corcoran Nicholas |
See Remarks |
• – – |
2025-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
12,676 |
33,781 |
|
- |
|
| Khayal Tamer I |
Chief Commercial Officer |
• – – |
2025-01-07 |
4 |
AS |
$80.05 |
$86,694 |
D/D |
(1,083) |
20,843 |
|
55% |
|
| Khayal Tamer I |
Chief Commercial Officer |
• – – |
2025-01-07 |
4 |
OE |
$13.28 |
$14,382 |
D/D |
1,083 |
21,926 |
|
- |
|
| Hernandez Gerardo |
Chief Financial Officer |
• – – |
2024-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
12,463 |
12,463 |
|
- |
|
| Khayal Tamer I |
Chief Commercial Officer |
• – – |
2024-12-02 |
4 |
AS |
$86.40 |
$93,658 |
D/D |
(1,084) |
20,843 |
|
2% |
|
| Khayal Tamer I |
Chief Commercial Officer |
• – – |
2024-12-02 |
4 |
OE |
$13.28 |
$14,396 |
D/D |
1,084 |
21,927 |
|
- |
|
| Khayal Tamer I |
Chief Commercial Officer |
• – – |
2024-11-11 |
4 |
AS |
$90.04 |
$131,278 |
D/D |
(1,458) |
20,843 |
|
-21% |
|
448 Records found
|
|
Page 1 of 18 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
1.39 (1.07%) 
